CLINICAL_TRIALS
trial_result
· 2015-12-16
Clinical Trial Update: Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI) [Phase 4]
Summary
A Phase 4 clinical trial evaluating policosanol to improve platelet reactivity after coronary stenting has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shenyang Northern Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED